Severe renal and pancreatic toxicities associated with ipilimumab and nivolumab combination therapy in non-small cell lung cancer: a pharmacovigilance analysis of the FDA adverse event reporting system
-
By
-
Jiongrui Cao
-
Li Peng
-
Jin Yang
-
Gang Yin
-
Ping Ke
-
Jifa Zhang
-
Min Su
-
Yun Gao
-
Yuehui Zhang
-
June 17, 2026
-
0 min
Top Institutions in Oncology
Brief introduction explaining scope and methodology.
-
#1
The University of Texas MD Anderson Cancer Center
Houston, Texas
-
#2
Memorial Sloan Kettering Cancer Center
New York, New York
-
#3
Sunnybrook Health Sciences Centre
Toronto, Ontario
-
#4
Kobe University
Kobe, Hyogo
-
#5
Yale Cancer Center
New Haven, Connecticut
